The Role of Alpha-Synuclein in Neurodegenerative Diseases: A Potential Target for New Treatment Strategies?

Publisher： Karger

E-ISSN： 1660-2862|5|3-4|218-221

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.5, Iss.3-4, 2008-03, pp. : 218-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of p53 in Neurodegenerative Diseases

By  

Neurodegenerative Diseases, Vol. 9, Iss. 2, 2011-10 ,pp. : 68-80

Karger

Access to resources Recommend Favorite

Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment

By Fang J.  

Apoptosis, Vol. 9, Iss. 1, 2004-01 ,pp. : 27-35

Springer Publishing Company

Access to resources Recommend Favorite

Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases

By  

Neurodegenerative Diseases, Vol. 15, Iss. 2, 2015-01 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

By  

Neurodegenerative Diseases, Vol. 5, Iss. 2, 2008-01 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders

By Bjarkam C.R.  

Biogerontology, Vol. 2, Iss. 3, 2001-01 ,pp. : 193-207

Springer Publishing Company

Access to resources Recommend Favorite